- Home
- MELI vs SNY Comparison
MELI vs SNY Comparison
Compare MELI & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MELI
- SNY
- Stock Information
- Founded
- MELI 1999
- SNY 1994
- Country
- MELI Uruguay
- SNY France
- Employees
- MELI N/A
- SNY N/A
- Industry
- MELI Catalog/Specialty Distribution
- SNY Biotechnology: Pharmaceutical Preparations
- Sector
- MELI Consumer Discretionary
- SNY Health Care
- Exchange
- MELI Nasdaq
- SNY Nasdaq
- Market Cap
- MELI 103.8B
- SNY 116.1B
- IPO Year
- MELI 2007
- SNY N/A
- Fundamental
- Price
- MELI $2,082.58
- SNY $49.73
- Analyst Decision
- MELI Strong Buy
- SNY Buy
- Analyst Count
- MELI 17
- SNY 4
- Target Price
- MELI $2,872.35
- SNY $61.50
- AVG Volume (30 Days)
- MELI 529.0K
- SNY 2.2M
- Earning Date
- MELI 10-29-2025
- SNY 10-24-2025
- Dividend Yield
- MELI N/A
- SNY 3.16%
- EPS Growth
- MELI 45.68
- SNY 105.93
- EPS
- MELI 40.97
- SNY 8.67
- Revenue
- MELI $26,193,000,000.00
- SNY $53,890,648,839.00
- Revenue This Year
- MELI $39.06
- SNY $2.37
- Revenue Next Year
- MELI $26.91
- SNY $6.51
- P/E Ratio
- MELI $50.25
- SNY $5.84
- Revenue Growth
- MELI 36.94
- SNY N/A
- 52 Week Low
- MELI $1,646.00
- SNY $44.62
- 52 Week High
- MELI $2,645.22
- SNY $60.12
- Technical
- Relative Strength Index (RSI)
- MELI 41.24
- SNY 45.01
- Support Level
- MELI $2,035.61
- SNY $48.55
- Resistance Level
- MELI $2,143.44
- SNY $52.67
- Average True Range (ATR)
- MELI 74.30
- SNY 0.73
- MACD
- MELI -10.80
- SNY -0.09
- Stochastic Oscillator
- MELI 21.90
- SNY 25.51
About MELI MercadoLibre Inc.
MercadoLibre runs the largest e-commerce marketplace in Latin America, with more than 218 million active users and 1 million active sellers across 18 countries stitching into its commerce network or fintech solutions when last reported. The company operates a host of complementary businesses to its core online shop, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago and Mercado Credito), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.